IDR 2260.0
(-3.42%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3748.83 Billion IDR | -2.74% |
2022 | 3854.46 Billion IDR | 30.91% |
2021 | 2944.4 Billion IDR | 13.61% |
2020 | 2591.59 Billion IDR | 94.42% |
2019 | 1332.95 Billion IDR | 48.74% |
2018 | 896.16 Billion IDR | 68.75% |
2017 | 531.06 Billion IDR | -8.36% |
2016 | 579.51 Billion IDR | -11.78% |
2015 | 656.93 Billion IDR | -7.84% |
2014 | 712.78 Billion IDR | -11.59% |
2013 | 806.23 Billion IDR | 38.45% |
2012 | 582.31 Billion IDR | 171.29% |
2011 | 214.64 Billion IDR | 25.21% |
2010 | 171.43 Billion IDR | 13.33% |
2009 | 151.27 Billion IDR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 3742.23 Billion IDR | -0.38% |
2024 Q1 | 3756.69 Billion IDR | 0.21% |
2023 Q4 | 3748.83 Billion IDR | -0.36% |
2023 Q2 | 3802.53 Billion IDR | -1.46% |
2023 Q1 | 3858.73 Billion IDR | 0.11% |
2023 Q3 | 3762.42 Billion IDR | -1.05% |
2023 FY | 3748.83 Billion IDR | -2.74% |
2022 Q1 | 2897.14 Billion IDR | -1.6% |
2022 Q2 | 2840.92 Billion IDR | -1.94% |
2022 Q3 | 2908.11 Billion IDR | 2.37% |
2022 Q4 | 3854.46 Billion IDR | 32.54% |
2022 FY | 3854.46 Billion IDR | 30.91% |
2021 Q1 | 2524.46 Billion IDR | -2.59% |
2021 Q3 | 3347.52 Billion IDR | 32.69% |
2021 FY | 2944.4 Billion IDR | 13.61% |
2021 Q2 | 2522.74 Billion IDR | -0.07% |
2021 Q4 | 2944.4 Billion IDR | -12.04% |
2020 FY | 2591.59 Billion IDR | 94.42% |
2020 Q3 | 2557.43 Billion IDR | 3.19% |
2020 Q1 | 1703.73 Billion IDR | 27.82% |
2020 Q2 | 2478.32 Billion IDR | 45.46% |
2020 Q4 | 2591.59 Billion IDR | 1.34% |
2019 Q4 | 1332.95 Billion IDR | 10.93% |
2019 FY | 1332.95 Billion IDR | 48.74% |
2019 Q1 | 1024.11 Billion IDR | 14.28% |
2019 Q2 | 1037.99 Billion IDR | 1.36% |
2019 Q3 | 1201.65 Billion IDR | 15.77% |
2018 Q2 | 692 Billion IDR | 31.81% |
2018 Q4 | 896.16 Billion IDR | 16.38% |
2018 FY | 896.16 Billion IDR | 68.75% |
2018 Q1 | 525 Billion IDR | -1.14% |
2018 Q3 | 770 Billion IDR | 11.27% |
2017 FY | 531.06 Billion IDR | -8.36% |
2017 Q1 | 561.95 Billion IDR | -3.03% |
2017 Q2 | 537.87 Billion IDR | -4.29% |
2017 Q3 | 489.07 Billion IDR | -9.07% |
2017 Q4 | 531.06 Billion IDR | 8.59% |
2016 Q1 | 659.99 Billion IDR | 0.47% |
2016 FY | 579.51 Billion IDR | -11.78% |
2016 Q2 | 734.25 Billion IDR | 11.25% |
2016 Q4 | 579.51 Billion IDR | -29.75% |
2016 Q3 | 824.97 Billion IDR | 12.36% |
2015 FY | 656.93 Billion IDR | -7.84% |
2015 Q4 | 656.93 Billion IDR | -4.1% |
2015 Q3 | 685.01 Billion IDR | -2.43% |
2015 Q2 | 702.09 Billion IDR | -1.23% |
2015 Q1 | 710.8 Billion IDR | -0.28% |
2014 FY | 712.78 Billion IDR | -11.59% |
2014 Q4 | 712.78 Billion IDR | -7.68% |
2014 Q3 | 772.06 Billion IDR | -1.55% |
2014 Q2 | 784.22 Billion IDR | -2.15% |
2014 Q1 | 801.42 Billion IDR | -0.6% |
2013 Q1 | 680.69 Billion IDR | 16.9% |
2013 Q2 | 960.1 Billion IDR | 41.05% |
2013 FY | 806.23 Billion IDR | 38.45% |
2013 Q3 | 838.59 Billion IDR | -12.66% |
2013 Q4 | 806.23 Billion IDR | -3.86% |
2012 Q3 | 425.57 Billion IDR | 39.56% |
2012 Q4 | 582.31 Billion IDR | 36.83% |
2012 Q2 | 304.93 Billion IDR | 24.67% |
2012 Q1 | 244.59 Billion IDR | 13.95% |
2012 FY | 582.31 Billion IDR | 171.29% |
2011 Q4 | 214.64 Billion IDR | 0.0% |
2011 FY | 214.64 Billion IDR | 25.21% |
2010 FY | 171.43 Billion IDR | 13.33% |
2009 FY | 151.27 Billion IDR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
PT Bundamedik Tbk | 1283.12 Billion IDR | -192.164% |
PT Metro Healthcare Indonesia Tbk | 1039.28 Billion IDR | -260.714% |
PT Medikaloka Hermina Tbk | 3604.32 Billion IDR | -4.009% |
PT Mitra Keluarga Karyasehat Tbk | 741.05 Billion IDR | -405.875% |
PT Murni Sadar Tbk | 708.74 Billion IDR | -428.939% |
PT Famon Awal Bros Sedaya Tbk | 1769.45 Billion IDR | -111.864% |
PT Royal Prima Tbk | 49.68 Billion IDR | -7445.14% |
PT Kedoya Adyaraya Tbk | 77.63 Billion IDR | -4728.865% |
PT Sarana Meditama Metropolitan Tbk | 1381.15 Billion IDR | -171.427% |
PT Siloam International Hospitals Tbk | 2934.42 Billion IDR | -27.754% |